SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001725160-24-000096
Filing Date
2024-04-29
Accepted
2024-04-29 16:34:30
Documents
23
Period of Report
2024-06-21

Document Format Files

Seq Description Document Type Size
1 DEF 14A zntl-20240429.htm   iXBRL DEF 14A 965769
6 GRAPHIC zntl-20240429_g1.jpg GRAPHIC 2890
7 GRAPHIC zntl-20240429_g2.jpg GRAPHIC 68307
8 GRAPHIC zntl-20240429_g3.jpg GRAPHIC 102465
9 GRAPHIC zntl-20240429_g4.jpg GRAPHIC 5757
10 GRAPHIC zntl-20240429_g5.jpg GRAPHIC 23785
11 GRAPHIC zntl-20240429_g6.jpg GRAPHIC 304751
12 GRAPHIC zntl-20240429_g7.jpg GRAPHIC 287456
13 GRAPHIC zntl-20240429_g8.jpg GRAPHIC 465584
14 GRAPHIC zntl-20240429_g9.jpg GRAPHIC 235919
  Complete submission text file 0001725160-24-000096.txt   5201838

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT zntl-20240429.xsd EX-101.SCH 2860
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT zntl-20240429_def.xml EX-101.DEF 3923
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT zntl-20240429_lab.xml EX-101.LAB 4072
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT zntl-20240429_pre.xml EX-101.PRE 2653
26 EXTRACTED XBRL INSTANCE DOCUMENT zntl-20240429_htm.xml XML 219942
Mailing Address 1359 BROADWAY, SUITE 801 NEW YORK NY 10018
Business Address 1359 BROADWAY, SUITE 801 NEW YORK NY 10018 (212) 433-3791
Zentalis Pharmaceuticals, Inc. (Filer) CIK: 0001725160 (see all company filings)

IRS No.: 823607803 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-39263 | Film No.: 24891640
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)